FD67006 PGIM保德信全球醫療生化基金-N累積型(美元) |
基金持股分佈(依持有類股) 資料日期:2024/10/18 |
|
基金持股分佈
資料日期:2024/09/30 |
|
基金持股分佈(依區域)
資料日期:2024/09/30 |
|
PGIM保德信全球醫療生化基金-N累積型(美元)-持股明細 資料月份:2024/09 |
股票名稱 | 持股(千股) | 比例 | 增減 |
股票名稱 | 持股(千股) | 比例 | 增減 |
ELI LILLY & CO |
N/A |
8.29 |
-0.45% |
MAX HEALTHCARE INSTITUTE LTD |
N/A |
2.31 |
N/A |
BRISTOL-MYERS SQUIBB CO |
N/A |
5.83 |
2.04% |
APELLIS PHARMACEUTICALS INC |
N/A |
2.26 |
N/A |
Unitedhealth Group Inc |
N/A |
4.94 |
0.14% |
PHATHOM PHARMACEUTICALS INC |
N/A |
2.05 |
N/A |
BOSTON SCIENTIFIC CORP |
N/A |
4.05 |
-0.52% |
QIAGEN N.V. |
N/A |
1.95 |
N/A |
INTUITIVE SURGICAL INC |
N/A |
3.98 |
-0.41% |
THE CIGNA GROUP |
N/A |
1.92 |
N/A |
NOVO NORDISK A/S-B |
N/A |
3.54 |
-0.53% |
DEXCOM INC |
N/A |
1.73 |
N/A |
VERTEX PHARMACEUTICALS INC |
N/A |
3.45 |
N/A |
VAXCYTE INC |
N/A |
1.47 |
N/A |
HUMANA INC |
N/A |
3.39 |
-0.30% |
ARCUTIS BIOTHERAPEUTICS INC |
N/A |
1.44 |
N/A |
AMGEN INC |
N/A |
3.35 |
-0.03% |
INSMED INC |
N/A |
1.42 |
N/A |
ARGENX SE |
N/A |
3.21 |
N/A |
APOLLO HOSPITALS ENTERPRISE |
N/A |
1.39 |
N/A |
Sanofi |
N/A |
3.02 |
N/A |
VERONA PHARMA PLC - ADR |
N/A |
1.39 |
N/A |
AGILENT TECHNOLOGIES INC |
N/A |
2.96 |
N/A |
MARAVAI LIFESCIENCES HLDGS-A |
N/A |
1.34 |
N/A |
MERCK & CO. INC. |
N/A |
2.96 |
-1.62% |
DYNE THERAPEUTICS INC |
N/A |
1.33 |
N/A |
Astrazeneca Plc |
N/A |
2.89 |
-0.27% |
INARI MEDICAL INC |
N/A |
1.18 |
N/A |
COOPER COS INC/THE |
N/A |
2.47 |
N/A |
KYMERA THERAPEUTICS INC |
N/A |
1.15 |
N/A |
CRINETICS PHARMACEUTICALS IN |
N/A |
2.34 |
N/A |
ALIGN TECHNOLOGY INC |
N/A |
1.00 |
N/A |
(1)股票型及平衡型基金自91年7月份起放寬為每月公布基金持股前五大個股名稱,及合計占基金淨資產價值之比例;每季(3、6、9、12月)公布基金投資個股內容及比例。
(2)國內募集投資國外之股票型基金,放寬為每季公布基金持股前五大個股名稱,及合計占基金淨資產價值之比例;每半年公布基金投資個股內容及比例。 |